Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
India flag India · Delayed Price · Currency is INR
101.00
-1.63 (-1.59%)
Sep 24, 2026, 3:29 PM IST

NSE:AAREYDRUGS Statistics

Total Valuation

NSE:AAREYDRUGS has a market cap or net worth of INR 2.90 billion. The enterprise value is 3.48 billion.

Market Cap2.90B
Enterprise Value 3.48B

Important Dates

The last earnings date was Friday, August 14, 2026.

Earnings Date Aug 14, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 28.45M
Shares Outstanding n/a
Shares Change (YoY) +1.07%
Shares Change (QoQ) n/a
Owned by Insiders (%) 39.03%
Owned by Institutions (%) 2.78%
Float 13.23M

Valuation Ratios

The trailing PE ratio is 80.19.

PE Ratio 80.19
Forward PE n/a
PS Ratio 0.70
PB Ratio 1.93
P/TBV Ratio 1.93
P/FCF Ratio n/a
P/OCF Ratio 28.63
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 96.03
EV / Sales 0.84
EV / EBITDA 52.20
EV / EBIT 97.11
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.40
Debt / EBITDA 9.12
Debt / FCF -26.74
Interest Coverage 0.63

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 1.49%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 10.59%
Revenue Per Employee 31.42M
Profits Per Employee 274,242
Employee Count 132
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NSE:AAREYDRUGS has paid 5.82 million in taxes.

Income Tax 5.82M
Effective Tax Rate 13.84%

Stock Price Statistics

The stock price has increased by +28.35% in the last 52 weeks. The beta is 1.25, so NSE:AAREYDRUGS's price volatility has been higher than the market average.

Beta (5Y) 1.25
52-Week Price Change +28.35%
50-Day Moving Average 86.75
200-Day Moving Average 77.72
Relative Strength Index (RSI) 63.63
Average Volume (20 Days) 260,417

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:AAREYDRUGS had revenue of INR 4.15 billion and earned 36.20 million in profits. Earnings per share was 1.27.

Revenue4.15B
Gross Profit 158.61M
Operating Income 35.80M
Pretax Income 42.02M
Net Income 36.20M
EBITDA 66.60M
EBIT 35.80M
Earnings Per Share (EPS) 1.27
Full Income Statement

Balance Sheet

The company has 33.98 million in cash and 607.49 million in debt, with a net cash position of -573.51 million.

Cash & Cash Equivalents 33.98M
Total Debt 607.49M
Net Cash -573.51M
Net Cash Per Share n/a
Equity (Book Value) 1.50B
Book Value Per Share 52.86
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 101.39 million and capital expenditures -124.11 million, giving a free cash flow of -22.72 million.

Operating Cash Flow 101.39M
Capital Expenditures -124.11M
Depreciation & Amortization 30.80M
Net Borrowing -376,000
Free Cash Flow -22.72M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 3.82%, with operating and profit margins of 0.86% and 0.87%.

Gross Margin 3.82%
Operating Margin 0.86%
Pretax Margin 1.01%
Profit Margin 0.87%
EBITDA Margin 1.61%
EBIT Margin 0.86%
FCF Margin n/a

Dividends & Yields

NSE:AAREYDRUGS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -1.07%
Shareholder Yield -1.07%
Earnings Yield 1.25%
FCF Yield -0.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4